These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38287668)

  • 1. Cardiometabolic Health: Actionable Prevention Strategies and New Care Models.
    Leonards O; Aguilar D
    Tex Heart Inst J; 2024 Jan; 51(1):. PubMed ID: 38287668
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiometabolic Center of Excellence: A Novel Care Delivery Model for Secondary Prevention of Cardiovascular Disease in Type 2 Diabetes.
    Thomas M; Magwire M; Gosch K; Sammour Y; Mehta R; O'Keefe J; Nassif ME; Kosiborod M
    Circ Cardiovasc Qual Outcomes; 2021 Oct; 14(10):e007682. PubMed ID: 34587753
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of cardiovascular risk in patients with type 2 diabetes mellitus as a component of the cardiometabolic syndrome.
    Ferdinand KC
    J Cardiometab Syndr; 2006; 1(2):133-40. PubMed ID: 17679832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and management of cardiometabolic risk in Canada: a position paper by the cardiometabolic risk working group (executive summary).
    ; Leiter LA; Fitchett DH; Gilbert RE; Gupta M; Mancini GB; McFarlane PA; Ross R; Teoh H; Verma S; Anand S; Camelon K; Chow CM; Cox JL; Després JP; Genest J; Harris SB; Lau DC; Lewanczuk R; Liu PP; Lonn EM; McPherson R; Poirier P; Qaadri S; Rabasa-Lhoret R; Rabkin SW; Sharma AM; Steele AW; Stone JA; Tardif JC; Tobe S; Ur E
    Can J Cardiol; 2011; 27(2):124-31. PubMed ID: 21459258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of diabetes and associated cardiometabolic risk factors on members: strategies for optimizing outcomes.
    Hoerger TJ; Ahmann AJ
    J Manag Care Pharm; 2008 Feb; 14(1 Suppl C):S2-14; quiz 15-6. PubMed ID: 18240890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nutrients and Cardiometabolic Health in Type 2 Diabetes.
    Tricò D
    Nutrients; 2023 May; 15(11):. PubMed ID: 37299480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prospect of Genomic, Transcriptomic, Epigenetic and Metabolomic Biomarkers for The Personalized Prevention of Type 2 Diabetes and Cardiovascular Diseases.
    Zeljkovic A; Mihajlovic M; Vujcic S; Guzonjic A; Munjas J; Stefanovic A; Kotur-Stevuljevic J; Rizzo M; Bogavac-Stanojevic N; Gagic J; Kostadinovic J; Vekic J
    Curr Vasc Pharmacol; 2023; 21(3):185-196. PubMed ID: 37165508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiovascular prevention in diabetes mellitus: A multifactorial challenge].
    Pedro-Botet J; Chillarón JJ; Benaiges D; Flores-Le Roux JA
    Clin Investig Arterioscler; 2016; 28(3):154-63. PubMed ID: 26655375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Association of Specific Dietary Patterns with Cardiometabolic Outcomes in Women with a History of Gestational Diabetes Mellitus: A Scoping Review.
    O'Hara H; Taylor J; Woodside JV
    Nutrients; 2023 Mar; 15(7):. PubMed ID: 37049454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clustering of health behaviors and their associations with cardiometabolic risk factors among adults at high risk for type 2 diabetes in India: A latent class analysis.
    de Mello GT; Thirunavukkarasu S; Jeemon P; Thankappan KR; Oldenburg B; Cao Y
    J Diabetes; 2024 May; 16(5):e13550. PubMed ID: 38708436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uric acid as a predictor of weight gain and cardiometabolic health in the Study of Novel Approaches to Weight Gain Prevention (SNAP) study.
    Corso LML; Wing RR; Tate DF; Espeland MA; Blanchard BE; McCaffery JM
    Int J Obes (Lond); 2022 Aug; 46(8):1556-1559. PubMed ID: 35501471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of aspirin therapy in patients with the cardiometabolic syndrome and diabetes.
    Gardner M; Palmer J; Manrique C; Lastra G; Gardner DW; Sowers JR
    J Cardiometab Syndr; 2009; 4(2):96-101. PubMed ID: 19614796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risk and cardiometabolic protection: role of glitazones.
    Petrazzi L; Grassi D; Polidoro L; D'Aurelio A; Croce G; Properzi G; Tiberti S; Desideri G; Ferri C
    J Nephrol; 2008; 21(6):826-35. PubMed ID: 19034866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mismatch between self-perceived and calculated cardiometabolic disease risk among participants in a prevention program for cardiometabolic disease: a cross-sectional study.
    Stol DM; Hollander M; Damman OC; Nielen MMJ; Badenbroek IF; Schellevis FG; de Wit NJ
    BMC Public Health; 2020 May; 20(1):740. PubMed ID: 32434574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risk in Gullah African Americans with high familial risk of type 2 diabetes mellitus: project SuGAR.
    Hunt KJ; Kistner-Griffin E; Spruill I; Teklehaimanot AA; Garvey WT; Sale M; Fernandes J
    South Med J; 2014 Oct; 107(10):607-14. PubMed ID: 25279862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inverse associations between serum levels of secreted frizzled-related protein-5 (SFRP5) and multiple cardiometabolic risk factors: KORA F4 study.
    Carstensen-Kirberg M; Kannenberg JM; Huth C; Meisinger C; Koenig W; Heier M; Peters A; Rathmann W; Roden M; Herder C; Thorand B
    Cardiovasc Diabetol; 2017 Aug; 16(1):109. PubMed ID: 28851362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long-term effects of Kerala Diabetes Prevention Program on diabetes incidence and cardiometabolic risk: a study protocol.
    Haregu T; Lekha TR; Jasper S; Kapoor N; Sathish T; Panniyammakal J; Tapp R; Thankappan KR; Mahal A; Absetz P; Fisher EB; Oldenburg B
    BMC Public Health; 2023 Mar; 23(1):539. PubMed ID: 36945029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of progressive resistance training combined with a whey-protein drink and vitamin D supplementation on glycaemic control, body composition and cardiometabolic risk factors in older adults with type 2 diabetes: study protocol for a randomized controlled trial.
    Daly RM; Miller EG; Dunstan DW; Kerr DA; Solah V; Menzies D; Nowson CA
    Trials; 2014 Nov; 15():431. PubMed ID: 25376884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cardiometabolic effect of current management of polycystic ovary syndrome: strategies of prevention and treatment.
    Baldani DP; Skrgatic L; Ougouag R; Kasum M
    Gynecol Endocrinol; 2018 Feb; 34(2):87-91. PubMed ID: 28944709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of objectively measured sedentary behaviour and physical activity with markers of cardiometabolic health.
    Henson J; Yates T; Biddle SJ; Edwardson CL; Khunti K; Wilmot EG; Gray LJ; Gorely T; Nimmo MA; Davies MJ
    Diabetologia; 2013 May; 56(5):1012-20. PubMed ID: 23456209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.